(Q35117060)

6 August 2017

1 reference

title

New developments in the pharmacological treatment of chronic heart failure (English)

1 reference

6 August 2017

chronic heart failure

1 reference

1

Henry Krum

1 reference

6 August 2017

2

Danny Liew

1 reference

PubMed ID

12720487

6 August 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

Expert Opinion on Investigational Drugs

6 August 2017

1 reference

6 August 2017

12

1 reference

6 August 2017

5

1 reference

6 August 2017

751-757

1 reference

A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure

6 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

Randomized, controlled trial of integrated heart failure management: The Auckland Heart Failure Management Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

Randomised controlled trial of specialist nurse intervention in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

Home-based intervention in congestive heart failure: long-term implications on readmission and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

Devices for the management of ventricular arrhythmias in cardiac failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

Myocyte death, growth, and regeneration in cardiac hypertrophy and failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

Cell therapy of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS). Rationale and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

Perindopril for elderly people with chronic heart failure: the PEP-CHF study. The PEP investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

Valsartan in acute myocardial infarction trial (VALIANT): rationale and design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

Rationale for the use of aldosterone antagonists in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

Diagnostic and therapeutic potential of the endothelin system in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

Endothelin and endothelin receptor antagonists in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

Endothelin antagonists and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

Role of tumour necrosis factor-alpha in the progression of heart failure: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

New therapeutic options in congestive heart failure: Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

Effects of a vasopressin antagonist with combined antipressor and antiantidiuretic activities in rats with left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

Neurohormonal antagonism in heart failure; beneficial effects of vasopressin V(1a) and V(2) receptor blockade and ACE inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

Acute hemodynamic effects of conivaptan, a dual V(1A) and V(2) vasopressin receptor antagonist, in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

Elevated serum and monocyte tumour necrosis factor alpha in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.751

10.1517/13543784.12.5.751

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12720487